PLAGL1 overexpression induces cytoplasmic DNA accumulation that triggers cGAS/STING activation

Area of Science:

• Immunology
• Endocrinology
• Molecular Biology

Background:

• Type 1 diabetes mellitus (T1DM) is an autoimmune disease primarily involving pancreatic beta cell destruction.
• The precise molecular mechanisms initiating T1DM pathogenesis remain incompletely understood.

Purpose of the Study:

• To investigate the role of PLAGL1 expression in pancreatic beta cell apoptosis.
• To elucidate the downstream signaling pathways activated by PLAGL1-induced apoptosis in T1DM.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) and Western blotting for gene and protein expression.
• Flow cytometry and TUNEL assay for apoptosis detection.
• In vivo studies in NOD/LtJ mice, including glucose-stimulated insulin secretion (GSIS) and glucose tolerance tests (GTT).
• Histological analysis using Hematoxylin and Eosin (H&E) and Immunohistochemistry (IHC).

Main Results:

• Elevated PLAGL1 expression induced beta cell apoptosis, evidenced by mitochondrial dysfunction and nucleolar degradation.
• PLAGL1-induced apoptosis led to cytoplasmic DNA accumulation, activating the cGAS-STING pathway.
• STING activation triggered IRF3 and NF-kB pathways, enhancing type-I interferon signaling and inflammation.

Conclusions:

• PLAGL1 overexpression is a molecular driver of beta cell apoptosis in T1DM.
• The cGAS-STING pathway is a critical mediator linking PLAGL1-induced apoptosis to inflammatory responses in T1DM.
• Targeting the cGAS-STING pathway presents a potential therapeutic strategy for T1DM treatment.